Watch ARQT. Know when insiders buy.
One email the day a filing lands. Free.
ARQT
Arcutis Biotherapeutics, Inc.
31.87
−0.95 −2.89%
USD · Oct 21, 06:00 p.m. ET
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
24
FLAG · insiders 25, shorts 22
Insiders, 90 days
−$1.6M
net selling · 0 buys, 8 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $4BP/E 151.8DIV YIELD —FCF YIELD 0.98%REV TTM $464M +76.1%NET INCOME $28.5MNET DEBT $74.8M52W 19.50 – 32.82SEC XBRL · TTM TO Invalid Date
One year, everything drawn on
Insider buyInsider sellCongress buy, above the lineCongress sell, below10-K / 10-Q filedHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-10-21
Insiders (90d): $1.6M net selling
Shorts (latest report): 16.6M short · +1.8M last period
Every line of the math24FLAG
Congress is trading it
ALL 3| Traded | Member | Type | Amount |
|---|---|---|---|
| May 29 | Gilbert Cisneros D·CA | Buy | $1K–$15K |
| Mar 3 | Gilbert Cisneros D·CA | Buy | $1K–$15K |
| Dec 11 | Gilbert Cisneros D·CA | Sell | $1K–$15K |
Insider activity
ALL 8| Date | Insider | Type | Value |
|---|---|---|---|
| Oct 15 | Director | Sell | $127K |
| Sep 16 | See Remarks | Sell | $92K |
| Sep 15 | Director | Sell | $114K |
| Sep 8 | See Remarks | Sell | $250K |
| Aug 27 | Director | Sell | $677K |
| Aug 27 | Director | Sell | $279K |